Literature DB >> 30099052

Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.

Sai Han1, Ying Wang1, Xuejiao Shi2, Liju Zong1, Lu Liu1, Juan Zhang1, Qiuhong Qian1, Jing Jin1, Yana Ma1, Baoxia Cui1, Xingsheng Yang1, Beihua Kong1, Youzhong Zhang3.   

Abstract

Although persistent human papilloma virus (HPV) infection exerts a crucial influence on cervical carcinogenesis, other factors are also involved in its development, such as intraepithelial lesions and cervical cancer. B7-H3 and B7-H4, which have been reported to be co-regulatory ligands in the B7 family, had been found to be overexpressed in cervical cancer and correlated with adverse clinicopathological features and poor prognosis in our previous studies. In this study, we sought to explore the effects of B7-H3 and B7-H4 on the cervical microenvironment. Among several immune cytokines, interleukin-10 (IL-10) and transforming growth factor (TGF) β1 stand out as important immunosuppressive factors. Our studies found that IL-10 expression increased with pathological change levels and significantly correlated with cervical cancer differentiation (P < 0.05). TGF-β1 correlated with lymph node metastasis (LNM) (P < 0.01). Expression of B7-H3 and B7-H4 positively correlated with the expression of IL-10 and TGF-β1. After co-culture, we found that overexpression of B7-H3 and B7-H4 in cervical cancer cell lines resulted in activation of the cell cycle and decreased apoptosis of U-937 cells. In addition, the contents of IL-10 and TGF-β1, as well as their protein expression levels, increased in co-culture supernatants in U-937 cells, suggesting regulation by the p-JAK2/STAT3 pathway. The in vivo results demonstrated that with the increasing expression of B7-H3/B7-H4, the expression of IL-10 and TGF-β1 also increased significantly. Overall, the expression of B7-H3 and B7-H4 favored an immunosuppressive microenvironment by promoting the production of IL-10 and TGF-β1, thereby resulting in progression of cervical carcinogenesis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B7-H3; B7-H4; Cervical cancer; Co-culture; IL-10, TGF-β1

Mesh:

Substances:

Year:  2018        PMID: 30099052     DOI: 10.1016/j.yexcr.2018.08.014

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Expression of B7 family checkpoint proteins in cervical cancer.

Authors:  Liju Zong; Yu Gu; Yuncan Zhou; Yujia Kong; Shengwei Mo; Shuangni Yu; Yang Xiang; Jie Chen
Journal:  Mod Pathol       Date:  2021-11-30       Impact factor: 7.842

2.  Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8.

Authors:  Anqi Li; Ningyue Zhang; Zhiming Zhao; Yali Chen; Liang Zhang
Journal:  Oncol Lett       Date:  2020-06-05       Impact factor: 2.967

3.  B7-H3 Induces Ovarian Cancer Drugs Resistance Through An PI3K/AKT/BCL-2 Signaling Pathway.

Authors:  Li Zhou; Yangchun Zhao
Journal:  Cancer Manag Res       Date:  2019-12-03       Impact factor: 3.989

4.  Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix.

Authors:  Liju Zong; Qianqian Zhang; Yuncan Zhou; Yujia Kong; Shuangni Yu; Jie Chen; Youzhong Zhang; Yang Xiang
Journal:  J Immunol Res       Date:  2020-04-03       Impact factor: 4.818

5.  Positive staining of the immunoligand B7-H6 in abnormal/transformed keratinocytes consistently accompanies the progression of cervical cancer.

Authors:  Gloria Yareli Gutierrez-Silerio; Ramon Antonio Franco-Topete; Jesse Haramati; Eduardo Miguel Navarrete-Medina; Jorge Gutierrez-Franco; Miriam Ruth Bueno-Topete; Blanca Estela Bastidas-Ramirez; Martha Eloisa Ramos-Marquez; Susana Del Toro-Arreola
Journal:  BMC Immunol       Date:  2020-03-06       Impact factor: 3.615

Review 6.  The complexity of tumour angiogenesis based on recently described molecules.

Authors:  Weronika Wiśniewska; Michał Kopka; Karolina Siemiątkowska; Marta Magdalena Fudalej; Aleksandra Sobiborowicz; Anna Maria Badowska-Kozakiewicz
Journal:  Contemp Oncol (Pozn)       Date:  2021-04-15

7.  Molecular and clinical features of a potential immunotherapy target ELK3 in glioma.

Authors:  Hao Xu; Li Zhang; Jin Gao; Jiajing Wang; Yihao Wang; Dongdong Xiao; Songshan Chai
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

8.  The role of low density lipoprotein receptor-related protein 11 as a tumor promoter in cervical cancer.

Authors:  Ying Wang; Sai Han; Xuewu You; Xuejiao Shi; Lu Liu; Yu Sun; Yana Ma; Qiuhong Qian; Hongli Liu; Baoxia Cui; Youzhong Zhang
Journal:  Cancer Manag Res       Date:  2019-08-30       Impact factor: 3.989

Review 9.  A review of the research progress in T-lymphocyte immunity and cervical cancer.

Authors:  Lina Zhang; Zhilei Mao; Yiqing Lai; Ting Wan; Keliang Zhang; Beibei Zhou
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

10.  Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer.

Authors:  Qianqian Zhang; Liju Zong; Hui Zhang; Wei Xie; Fan Yang; Wenwen Sun; Baoxia Cui; Youzhong Zhang
Journal:  Onco Targets Ther       Date:  2021-07-23       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.